http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-033284-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2432444fb30589a7e99bd8bd5ef44e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a82b288d4285c71abd1507cf588d26f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b196d072e478983e0bcd89192f5954c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca522bcb5779e48c5bf8ccf0e0ab01ad
publicationDate 2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-033284-B1
titleOfInvention 8- [6- [3- (AMINO) PROPOXY] -3-pyridyl] -1-isopropyl-imidazo [4,5-c] quinolin-2-one derivatives as selective kinetics modulators of an ataxia-atomic mutation kinase) CANCER TREATMENT
abstract The present invention generally relates to compounds of formula (I) and their pharmaceutically acceptable salts, where R, R, R, R and R have any meanings as defined herein. The invention also relates to the use of compounds of formula (I) and their salts for the treatment or prevention of diseases mediated by ATM, including cancer. The invention further relates to pharmaceutical compositions comprising substituted imidazo [4,5-c] quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods for the production of such compounds and salts; and intermediates useful for such production.
priorityDate 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015084384-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015170081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102399218-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102372711-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126689777
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428715467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66919853
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID300711
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403064
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421334650
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526824
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479450
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451530

Total number of triples: 37.